» Authors » Rebeca Vidal

Rebeca Vidal

Explore the profile of Rebeca Vidal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 683
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Malan-Muller S, Vidal R, OShea E, Montero E, Figuero E, Zorrilla I, et al.
Transl Psychiatry . 2024 Oct; 14(1):419. PMID: 39368974
The role of the oral microbiome in mental health has recently been appreciated within the proposed oral-brain axis. This study examined the structure and composition of the salivary microbiome in...
2.
Gil de Biedma-Elduayen L, Gimenez-Gomez P, Morales-Puerto N, Vidal R, Nunez-de la Calle C, Gutierrez-Lopez M, et al.
Br J Pharmacol . 2022 Feb; 179(14):3711-3726. PMID: 35189673
Background And Purpose: The kynurenine pathway has been proposed as a target for modulating drug abuse. We previously demonstrated that inhibition of kynurenine 3-monooxygenase (KMO), using Ro 61-8048, reduces ethanol...
3.
Gimenez-Gomez P, Ballestin R, Gil de Biedma-Elduayen L, Vidal R, Ferrer-Perez C, Reguilon M, et al.
Neuropharmacology . 2021 Aug; 197:108753. PMID: 34389399
The kynurenine (KYN) pathway of tryptophan (TRP) degradation is activated by stress and inflammatory factors. It is now well established that social stress induces the activation of the immune system,...
4.
Morales-Puerto N, Gimenez-Gomez P, Perez-Hernandez M, Abuin-Martinez C, Gil de Biedma-Elduayen L, Vidal R, et al.
Pharmacol Ther . 2021 Jan; 223:107807. PMID: 33476641
Drug use poses a serious threat to health systems throughout the world and the number of consumers rises relentlessly every year. The kynurenine pathway, main pathway of tryptophan degradation, has...
5.
Vidal R, Garcia-Marchena N, OShea E, Requena-Ocana N, Flores-Lopez M, Araos P, et al.
Prog Neuropsychopharmacol Biol Psychiatry . 2020 May; 102:109958. PMID: 32360814
Background: Alterations in tryptophan (TRP) metabolism has been linked to drug exposure and mental disorders. However, most of studies have been performed without considering the co-occurrence of both disorders in...
6.
Garro-Martinez E, Vidal R, Adell A, Diaz A, Castro E, Amigo J, et al.
Mol Neurobiol . 2019 Dec; 57(3):1704-1715. PMID: 31823197
We previously reported that the inactivation (cKO) or the stabilization (cST) of β-catenin in cells expressing the astrocyte-specific glutamate aspartate transporter (GLAST) is associated with the vulnerability or resilience to...
7.
Araos P, Vidal R, OShea E, Pedraz M, Garcia-Marchena N, Serrano A, et al.
Sci Rep . 2019 Nov; 9(1):16842. PMID: 31727978
The lack of effective treatments and a high rate of relapse in cocaine addiction constitute a major health problem. The present study was conducted to examine the expression of tryptophan-derived...
8.
Vidal R, Venegas-Caleron M
J Microbiol Methods . 2019 Aug; 164:105686. PMID: 31400361
Glycogen is a highly soluble branched polymer composed of glucose monomers linked by glycosidic bonds that represents, together with starch, one of the main energy storage compounds in living organisms....
9.
Vidal R, Garro-Martinez E, Diaz A, Castro E, Florensa-Zanuy E, Taketo M, et al.
Mol Neurobiol . 2018 May; 56(1):553-566. PMID: 29737454
β-catenin (key mediator in the Wnt signaling pathway) contributes to the pathophysiology of mood disorders, associated to neurogenesis and neuroplasticity. Decreased β-catenin protein levels have been observed in the hippocampus...
10.
Gimenez-Gomez P, Perez-Hernandez M, Gutierrez-Lopez M, Vidal R, Abuin-Martinez C, OShea E, et al.
Neuropharmacology . 2018 Apr; 135:581-591. PMID: 29705534
Recent research suggests that ethanol (EtOH) consumption behaviour can be regulated by modifying the kynurenine (KYN) pathway, although the mechanisms involved have not yet been well elucidated. To further explore...